Nursing and Health Professions
Heart Ejection Fraction
100%
Heart Failure with Preserved Ejection Fraction
100%
Transthyretin
100%
Myocardial Disease
100%
Amyloid Protein
100%
Prevalence
70%
Scintigraphy
60%
Pyrophosphate
50%
Patient Referral
40%
Area under the Curve
20%
Predictive Value
20%
Receiver Operating Characteristic
10%
Heart Ventricle Hypertrophy
10%
Cohort Analysis
10%
Congestive Heart Failure
10%
Logistic Regression Analysis
10%
Female Patient
10%
Pyrophosphate Technetium Tc 99m
10%
Medicine and Dentistry
Ejection Fraction
100%
Transthyretin
100%
Heart Failure with Preserved Ejection Fraction
100%
Amyloid Cardiomyopathy
100%
Prevalence
70%
Scintigraphy
60%
Pyrophosphate
50%
Patient Referral
40%
Clinical Trial
20%
Logistic Regression Analysis
10%
Retrospective Cohort Study
10%
Cohort Effect
10%
Ventricular Hypertrophy
10%
Congestive Heart Failure
10%
Pyrophosphate Technetium Tc 99m
10%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure with Preserved Ejection Fraction
100%
Prevalence
100%
Amyloid Protein
100%
Myocardial Disease
100%
Transthyretin
100%
Pyrophosphate
71%
Clinical Trial
28%
Cohort Study
14%
Congestive Heart Failure
14%
Heart Ventricle Hypertrophy
14%
Pyrophosphate Technetium Tc 99m
14%
Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Transthyretin Amyloid Cardiomyopathy
100%
ATTR-CM
100%
HF with Preserved Ejection Fraction
44%
99mTc-pyrophosphate Scintigraphy
33%
External Validation
16%
Community Validation
16%
Clinical Trials
11%
Validation Cohort
11%
High Risk
11%
Ejection Fraction
11%
Northwestern University
5%
Chicago
5%
Diverse Populations
5%
Patients with Heart Failure
5%
Clinically Significant
5%
Illinois
5%
Rochester
5%
Area under the Receiver Operating Characteristic Curve
5%
Predictive Models
5%
Positive Predictive Value
5%
Clinical Score
5%
Mayo Clinic
5%
Older Patients
5%
Performance Measures
5%
Minnesota
5%
Predictive Value
5%
Epidemiology Study
5%
Risk Score
5%
Retrospective Cohort Study
5%
Hypertension Diagnosis
5%
Logistic Regression Model
5%
Female Patients
5%
Technetium-99m
5%
Technetium
5%
Male Sex
5%
Point-based
5%
Left Ventricular Wall Thickness
5%
Classification Performance
5%
Outcome Performance
5%
Posterior Wall Thickness
5%
Relative Wall Thickness
5%
Precision-recall Curve
5%
Biochemistry, Genetics and Molecular Biology
Heart Ejection Fraction
100%
Transthyretin
100%
Amyloid Protein
100%
Prevalence
58%
Pyrophosphate
50%
Clinical Trial
16%
Cohort Study
8%